BSGM Research and Charts

BSGM - BioSig Technologies Inc (Healthcare: Medical Devices)

Projected Earnings Date: 2022-11-13 (Delayed quote data 2025-05-08)

Last 1.79	Change ⇑ +0.32 (+21.77%)	Volume 711,314
	Open 1.49	High 1.82	Low 1.46

8EMA (Daily) 1.38	40EMA (Daily) 0.93	50EMA (Daily) 0.91	STO (Daily) 94.743	MACD Hist (Daily) 0.190
8EMA (Weekly) 1.069	40EMA (Weekly) 1.15	50EMA (Weekly) 1.37	STO (Weekly) 56.931	MACD Hist (Weekly) 0.224


Company Profile
BioSig Technologies Inc is a medical technology company. The firm is commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. Its first product, PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The company's subsidiary is seeking to develop a novel pharmaceutical called merimepodib to treat patients with COVID-19.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.